Mankind Pharma Makes a Move into the Agri-Tech Sector Plans to Invest Rs 200 Crore.
Synopsis : Mankind Pharma is planning to invest up to Rs 200 crore in the first two to three years in the…
Synopsis : Mankind Pharma is planning to invest up to Rs 200 crore in the first two to three years in the…
Synopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental maternal vaccine for respiratory syncytial virus (RSV).…
SYNOPSIS: GlaxoSmithKline Plc released positive trial results for a potential blockbuster anemia pill the company is hoping will bolster its pharma portfolio…